EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

The Promise of RNA Interference as a Pharmaceutical Tool

Dr. Maria J. Smith

American Journal of Pharmaceutics · 2022-10-31 · 3 (5) · 1-12

DOI: 10.71465/ajph2174 ↗

At a glance

Journal article in American Journal of Pharmaceutics, published online on 2022-10-31. Written by Dr. Maria J. Smith. The full text is freely available (open access, CC BY 4.0).

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

RNA interference (RNAi) is a natural cellular process that regulates gene expression by silencing specific messenger RNAs (mRNAs), thereby preventing the translation of genes into proteins. RNAi has emerged as a promising tool for pharmaceutical applications, enabling the targeted suppression of disease-related genes, including those involved in cancer, viral infections, genetic disorders, and autoimmune diseases. This article explores the potential of RNAi as a therapeutic approach, highlighting its mechanisms, challenges, and progress in clinical applications. Despite the therapeutic promise, several hurdles such as efficient delivery systems, off-target effects, and long-term safety remain. The future of RNAi-based therapeutics will likely depend on overcoming these challenges and optimizing RNAi delivery techniques.

Cite

APA

Smith, D. M. J. (2022). The Promise of RNA Interference as a Pharmaceutical Tool. American Journal of Pharmaceutics, 3(5), 1-12. https://doi.org/10.71465/ajph2174

Vancouver

Smith DMJ. The Promise of RNA Interference as a Pharmaceutical Tool. American Journal of Pharmaceutics. 2022;3(5):1-12. doi:10.71465/ajph2174

BibTeX
@article{Smith2022,
  author = {Smith, Dr. Maria J.},
  title = {The Promise of RNA Interference as a Pharmaceutical Tool},
  journal = {American Journal of Pharmaceutics},
  year = {2022},
  volume = {3},
  number = {5},
  pages = {1--12},
  doi = {10.71465/ajph2174}
}
Start for free →